PDS Biotechnology

Merck KGaA hands over IL-12-targeting cancer med to PDS Biotech in $121M deal
Fierce Biotech
Tue, 01/3/23 - 10:26 pm
Merck KGaA
R&D
PDS Biotechnology
ASCO 2021 movers – PDS wins, but big pharma reigns
EP Vantage
Wed, 06/9/21 - 11:00 am
ASCO 2021
PDS Biotechnology
Spectrum Pharma
Black Diamond Therapeutics
Alpine Immune Sciences
Harpoon Therapeutics
Macrogenics
PDS Biotechnology Files for $14 Million Offering
CP WIre
Wed, 12/18/19 - 10:32 am
PDS Biotechnology
PDS0101
HPV head and neck cancer
PDS Biotechnology Files for $14 Million Offering
Wed, 12/18/19 - 09:55 am
PDS Biotechnology
PDS0101
HPV head and neck cancer
After Head Injury Drug Fails, Edge Merges with Immuno-Oncology Firm PDS
Xconomy
Mon, 11/26/18 - 10:04 am
Edge Therapeutics
head injury
clinical trials
M&A
PDS Biotechnology
immuno-oncology